TrialNature medicine2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.
Fabian Müller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it
TrialNature medicine2026
Fabian Müller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.